Advait Gupta

5682 POSTS
Advait is our expert writer and manager for the Artificial Intelligence category. His passion for AI research and its advancements drives him to deliver in-depth articles that explore the frontiers of this rapidly evolving field. Advait's articles delve into the latest breakthroughs, trends, and ethical considerations, keeping readers at the forefront of AI knowledge.

Exclusive articles:

Hotter than the sun: Groundbreaking nuclear fusion technology slashes flight time to Mars

Revolutionizing interplanetary travel with unprecedented speed: Pulsar Fusion's nuclear fusion rocket could change the future of space exploration.

Rocsys Aims to Automate Electric Vehicle Charging, Starting with Ports and Yards

Transforming electric vehicle charging with Rocsys' innovative robotic arm. Enhance logistics automation and comply with regulations. Partnerships with major industry players. Series A funding supports expansion.

MosaicML CEO Naveen Rao: Democratizing Generative AI and the $1.3B Sale to Databricks

Discover how MosaicML CEO Naveen Rao helps businesses unlock the power of generative AI and large language models while preserving control of their data and reducing costs. Join his session at VB Transform on July 12, 2023.

Djuna Reveals Insights into their Captivating New Sci-Fi Book from South Korea

Discover the enigmatic sci-fi legend, Djuna, as they open up about their highly anticipated new book and influences. Dive into the world of Counterweight, a thrilling cyberpunk tale that explores memory implantation, space colonization, and identity. Don't miss this captivating English translation!

Solaris Secures $42M Funding Round at $1.6B Valuation to Expand Embedded Finance Operations Post-Challenging 2022

German fintech Solaris raises €38 million ($41.8 million) in Series F funding, boosting its embedded finance platform.

Breaking

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.
spot_imgspot_img